Risks include infection, bleeding, changes in hormone levels, and potential impacts on sexual health and urinary function.

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease.

Anyone at risk of hepatitis B exposure or needing routine screening should undergo this test. This includes individuals with potential exposure through sexual contact, blood transfusions, or needle-sharing.

Yes, the HBSAg Spot Test is highly accurate in detecting hepatitis B surface antigen. However, a positive result requires confirmation through additional tests.

No, additional tests are needed to differentiate between acute and chronic hepatitis B infection.

A positive result indicates possible hepatitis B infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.